Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus.
By L. Muller, K. Gorter, E. Hak, W. L. Goudzwaard, F. Schellevis, A. Hoepelman, G. Rutten. Clinical Infectious Diseases, 2005
1,026 citations recorded by the source corpus.
Subfields: Endocrinology, Diabetes and Metabolism, Genetics
View Paper: https://www.semanticscholar.org/paper/4e3d4a4675dc0dde7a6999269b0e799c1185eb00
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- M. Brouwer
- A. Tunkel
- D. van de Beek
- V. Hall
- R. Thomsen
- O. Henriksen
- N. Lohse
Citations in the corpus
- Diabetes is a risk factor for the progression and prognosis of COVID‐19 (2020, neutral): “15]), ESR (26 [13-58] vs 8 [7-26]), IL-6 (13.”
- Epidemiology, Diagnosis, and Antimicrobial Treatment of Acute Bacterial Meningitis (2010, background): “Alcoholism, human immunodeficiency virus (HIV) infection, diabetes mellitus, the use of immunosuppressive drugs, asplenia, and cancer may cause dysfunction of the immune system and thereby increase the risk of invasive infections, including meningitis (220, 223, 227).”
- Diabetes in Sub Saharan Africa 1999-2011: Epidemiology and public health implications. a systematic review (2011, background): “Type 2 diabetes is associated with a 25-75% increased risk of pneumonia and pneumococcal bacteremia leading to hospitalisation [106-111], and longer duration of diabetes, diabetes complications, and poor long-term glycemic control increase the risk [108,112].”